AI Science Tracker

AI-assisted discovery of antifibrotic compounds

Westlake University; Tsinghua University · 4 Nov 2026 · medicine

Discovery

AI-assisted discovery of antifibrotic compounds

Source check: Needs source check. Not independent scientific confirmation.

Finding / tested result: The preprint reports preclinical tests of model-selected compounds, including an animal-model result. It does not establish human efficacy.

Technology: GEMGen autoregressive large language model and compound-response scorer

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
GEMGen autoregressive large language model and compound-response scorer is the AI method documented in the editorial source review.
Limitation / still unknown
The date refers to the cited version. Earlier public versions and independent replication were not systematically verified.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.21203/rs.3.rs-11151710/v1

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.